New research presents a solution to a fundamental challenge: ensuring accurate glucose readings from wearable devices. Read more.

Glucose Monitoring Devices MarketAs the global burden of diabetes continues to grow, the need for accurate and efficient ...

Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Medical device maker Dexcom beat Wall Street estimates for third-quarter revenue and profit on Thursday, helped by resilient ...

A new consensus statement offers “considerations and good practice points” for the use of continuous glucose monitoring ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Insulin affordability and availability across Europe are just part of the complex diabetes management dynamics challenging ...

Rollme has launched the X3 smartwatch, making a significant impact in the global market with its advanced health monitoring features at an affordable price. This smartwatch is particularly noted for ...

The company offers blood glucose monitoring systems, continuous glucose monitoring systems, and diabetes application; patient and record billing software, including electronic medical record ...

The Global Patient Monitoring Devices Market will grow at a compound annual growth rate (CAGR) of 9.8% during the forecast period from 2022-2030. Request To Download Sample of This Strategic Report @ ...

Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2024 investor letter. A copy of ...